SIDE-EFFECTS OF RATIONAL DOSE I-131 THERAPY FOR METASTATIC WELL-DIFFERENTIATED THYROID-CARCINOMA

被引:0
作者
VANNOSTRAND, D
NEUTZE, J
ATKINS, F
机构
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1519 / 1527
页数:9
相关论文
共 8 条
[1]  
BEIERWALTES WH, 1983, THYROID TODAY, V6, P1
[2]  
BENUA RS, 1962, AMER J ROENTGENOL RA, V87, P171
[3]  
FREEMAN LM, 1983, NUCLEAR MED ANN 1983, P329
[4]  
LEEPER R, 1982, THYROID TODAY, V5, P1
[5]   TREATMENT OF METASTATIC THYROID-CANCER [J].
LEEPER, RD ;
SHIMAOKA, K .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1980, 9 (02) :383-404
[6]   EFFECT OF I-131 THERAPY ON SURVIVAL OF PATIENTS WITH METASTATIC PAPILLARY OR FOLLICULAR THYROID-CARCINOMA [J].
LEEPER, RD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (06) :1143-1152
[7]   RELATION BETWEEN EFFECTIVE RADIATION-DOSE AND OUTCOME OF RADIOIODINE THERAPY FOR THYROID-CANCER [J].
MAXON, HR ;
THOMAS, SR ;
HERTZBERG, VS ;
KEREIAKES, JG ;
CHEN, IW ;
SPERLING, MI ;
SAENGER, EL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (16) :937-941
[8]   LIMITATIONS AND INDICATIONS IN THE TREATMENT OF CANCER OF THE THYROID WITH RADIOACTIVE IODINE [J].
RAWSON, RW ;
RALL, JE ;
PEACOCK, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY, 1951, 11 (10) :1128-1142